Stephen Stranks - Concepedia

Author

Stephen Stranks

Also Known As

Joseph Proietto, S Stranks, S. N. Stranks, S. Stranks, STEPHEN STRANKS, Stephen N Stranks, Stephen N. Stranks, Stephen Stranks

Publications

3.8K

Citations

H-Index

Concepts

All Affiliations

Flinders University Repatriation General Hospital Flinders Medical Centre The University of Melbourne The University of Sydney

About

Stephen Stranks is an author at Flinders University specializing in diabetes, medicine, and pharmacotherapy.

Top Concepts

#	Concept	H-Index	Publications	Citations
1	Medicine	7	7	1.7K
2	Public Health	3	3	347
3	Health Sciences	2	2	141
4	Applied Physiology	1	1	19
5	Biostatistics	1	1	42

Stephen Stranks

Publications

3.3K

Citations

H-Index

Page 1

	Year	Citations
Atrasentan and renal events in patients with type 2 diabetes and chronic kidney disease (SONAR): a double-blind, randomised, placebo-controlled trial Hiddo J.L. Heerspink, Hans‐Henrik Parving, Dennis L. Andress, The Lancet UrologyRenal DiseaseRenal EventsRenal FunctionDiabetes	2019	589
Relative Hyperglycemia, a Marker of Critical Illness: Introducing the Stress Hyperglycemia Ratio G.W. Roberts, Stephen Quinn, Nyoli Valentine, The Journal of Clinical Endocrinology & Metabolism	2015	577
Once weekly exenatide compared with insulin glargine titrated to target in patients with type 2 diabetes (DURATION-3): an open-label randomised trial Michaëla Diamant, Luc Van Gaal, Stephen Stranks, The Lancet Diabetes ManagementInsulin GlargineInsulin ManagementDiabetesPharmacology	2010	435
Efficacy and safety of dapagliflozin in patients with inadequately controlled type 1 diabetes (DEPICT-1): 24 week results from a multicentre, double-blind, phase 3, randomised controlled trial Paresh Dandona, Chantal Mathieu, Moshe Phillip, The Lancet Diabetes & Endocrinology Metabolic SyndromeType 1Diabetes ManagementHealth PolicyCardiovascular Disease	2017	286
Continuous Monitoring of Circadian Glycemic Patterns In Patients Receiving Prednisolone For COPD Morton G. Burt, G.W. Roberts, Norma R. Aguilar-Loza, The Journal of Clinical Endocrinology & Metabolism	2011	202
Exenatide once weekly versus insulin glargine for type 2 diabetes (DURATION-3): 3-year results of an open-label randomised trial Michaëla Diamant, Luc Van Gaal, Bruno Guerci, The Lancet Diabetes & Endocrinology Diabetes ManagementInsulin ManagementDiabetesPharmacologyClinical Trials	2014	152
Six Months of Hybrid Closed-Loop Versus Manual Insulin Delivery With Fingerprick Blood Glucose Monitoring in Adults With Type 1 Diabetes: A Randomized, Controlled Trial Sybil A. McAuley, Melissa H. Lee, Barbora Paldus, Diabetes Care	2020	146
Regulation of the insulin-like growth factors and their binding proteins by glucocorticoid and growth hormone in nonislet cell tumor hypoglycemia. Robert C. Baxter, Sara Holman, A. Corbould, The Journal of Clinical Endocrinology & Metabolism Insulin-like Growth FactorsPathologyBinding ProteinsGlucocorticoidInsulin Signaling	1995	122
Relative Hyperglycemia Is an Independent Determinant of In-Hospital Mortality in Patients With Critical Illness Tien F. Lee, Sophie M. Drake, G.W. Roberts, Critical Care Medicine	2020	112
Effect of a Hybrid Closed-Loop System on Glycemic and Psychosocial Outcomes in Children and Adolescents With Type 1 Diabetes Mary B. Abraham, Martin de Bock, Grant J. Smith, JAMA Pediatrics	2021	111

Page 1